Drug Delivery Partnerships Conference: “Leveraging Med Device Expertise to Develop Combination Products”
Smith D. Presentation at Drug Delivery Partnerships, Palm Gardens, Florida February 10, 2017
During the 2017 Drug Delivery Partnerships Conference (DDP), Dirk Smith, Co-founder of Minnetronix, spoke about key factors to consider when integrating a drug delivery system into a combination therapy. Understanding the medical device mindset and framework - including timing, risk management, design controls, and systems complexity - can help leverage concurrent development processes to a successful market introduction.
Smith D. Presentation at DeviceTalks West, Newport, California, December 12, 2016
From the drive towards personalized medicine to big data and connectivity, Dirk Smith spoke about the role of technology in the changing landscape of patient care.
Terrafranca N., CEO, NeuroRecovery Technologies. Presentation at DeviceTalks West, Newport, California, December 12, 2016
Nick Terrafranca discussed how advances in wearable and implantable technology and device and data connectivity combined with a push for more individualized, cost-effective care will redefine the tools physician’s reach for in ten years.
DeviceTalks West: Pushing the Innovation Boundary for Patient Care: Opportunities and Responsibilities for Big Device Companies
Thierfelder, C. Director of Research and Development, Halyard Health West. Presentation at DeviceTalks West, Newport, California, December 12, 2016
With a widening innovation gap and an increasingly high barrier to entry and success, Chris Thierfelder spoke about the opportunities, and the responsibilities, of large companies in the medical device space to push the boundaries of innovation for patient care.
Thierfelder, C., Smith, D., Terrafranca, N. Panel presentation at DeviceTalks West, Newport, California, December 12, 2016
The audience questions following the MedTech 2025 panel presentations generated additional insight and perspective from the panelists on the future of the medtech industry.
Hedstrom B, et al. Poster Presentation at IDWeek 2016, New Orleans, LA, October 26-30, 2016
The poster presented data on reduction of C. neoformans in cerebrospinal fluid (CSF) in laboratory models using Minnetronix’ Neurapheresis™ CSF Filtration concept. This research investigates feasibility of neurapheresis to treat cryptococcal meningitis in humans